Fundz

Mandrake Bio has raised Rs 16 crore in a pre-seed funding round co-led by Activate and Antler, aimed at expanding its AI protein-design platform and validating gene-editing enzymes.

PRIVATEJul 16, 2026

Amount Raised

₹160 Million

Round Type

Pre-Seed

BengaluruBiotechnologyAgriculture and FarmingArtificial IntelligenceMachine Learning

Investors

De VCSpectrum ImpactDevcVijay ChandruParas ChopraSanjiv RangrassVatsal DusadActivateAntler

Description

Bengaluru-based biotech startup Mandrake Bio has raised Rs 16 crore in a pre-seed funding round co-led by Activate and Antler. The funds will be used to build AI-designed gene-editing enzymes for agriculture and therapeutics. Mandrake Bio is pre-revenue, focusing on validating its enzymes for commercial licensing to seed and therapeutic companies. The company aims to develop crops that are more resilient to climate change and require fewer pesticides.

Who to call at Mandrake Bio, and when

A new round usually means Mandrake Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mandrake Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mandrake Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mandrake Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mandrake Bio

Location

Bengaluru, Karnataka, India

About

Mandrake Bio is a Bengaluru-based biotech startup developing AI-designed gene-editing enzymes. The company creates these enzymes from scratch using artificial intelligence and protein design, rather than modifying existing natural enzymes. Its primary focus is on agricultural applications to improve crop resilience and reduce the need for pesticides and fertilizers. Founded by Tanay Lohia and Dr. Kutubuddin Molla, Mandrake Bio aims to license its innovations to seed and therapeutic companies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mandrake Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Mandrake Bio's next move

See what Strategic adds

Mandrake Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.